2019 - Fellow of the Royal Society, United Kingdom
Fellow of The Academy of Medical Sciences, United Kingdom
His scientific interests lie mostly in Virology, Immunology, Cytotoxic T cell, Virus and Immune system. His Virology research incorporates elements of T cell, In vivo, CTL* and Antigen. His study in T lymphocyte, CD8, Tropical spastic paraparesis, Human leukocyte antigen and Epitope falls under the purview of Immunology.
His biological study deals with issues like Viral replication, which deal with fields such as Reverse transcriptase. His Virus study combines topics from a wide range of disciplines, such as Major histocompatibility complex and Provirus. The Immune system study combines topics in areas such as Endocrinology, Lymphocyte and Arginase.
Virology, Immunology, Cytotoxic T cell, Virus and Immune system are his primary areas of study. The study incorporates disciplines such as T cell, CTL*, CD8 and Provirus in addition to Virology. Immunology is closely attributed to Disease in his work.
His research integrates issues of Epitope, Human leukocyte antigen, Antigen and In vivo in his study of Cytotoxic T cell. His specific area of interest is Virus, where he studies Viral replication. He has researched Tropical spastic paraparesis in several fields, including Peripheral blood mononuclear cell and Asymptomatic carrier.
His primary scientific interests are in Virology, Provirus, Immunology, Cytotoxic T cell and Lymphoma. His Virology research is multidisciplinary, incorporating elements of T cell, Antibody and Clone. His studies deal with areas such as Chromatin, Retrovirus and Transcription as well as Provirus.
His research on Immunology often connects related areas such as Malignancy. His work deals with themes such as In vivo, Peripheral blood mononuclear cell and CD8, Antigen, which intersect with Cytotoxic T cell. His study on Lymphoma also encompasses disciplines like
Charles R. M. Bangham focuses on Virology, Provirus, Retrovirus, Immunology and Human T-lymphotropic virus 1. His Virology research is multidisciplinary, incorporating perspectives in Cytotoxic T cell, Leukemia, Haematopoiesis and T cell. His work carried out in the field of Cytotoxic T cell brings together such families of science as Peripheral blood mononuclear cell, CD8, Antigen and Bone marrow.
His research in Immunology intersects with topics in Malignancy and Disease. His Human T-lymphotropic virus 1 study combines topics in areas such as HTLV-1 Infection and Antibody. His study explores the link between Virus and topics such as Pathogenesis that cross with problems in Lentivirus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Population dynamics of immune responses to persistent viruses.
Martin A. Nowak;Charles R. M. Bangham.
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
Rodney E. Phillips;Sarah Rowland-Jones;Douglas F. Nixon;Frances M. Gotch.
POSITIVE SELECTION OF HIV-1 CYTOTOXIC T LYMPHOCYTE ESCAPE VARIANTS DURING PRIMARY INFECTION
David A. Price;Philip J. R. Goulder;Paul Klenerman;Andrew K. Sewell.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp
Masahiro Nagai;Koichiro Usuku;Wataru Matsumoto;Daisuke Kodama.
Journal of NeuroVirology (1998)
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.
Tadahiko Igakura;Jane C. Stinchcombe;Peter K. C. Goon;Graham P. Taylor.
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
Katie J. M. Jeffery;Koichiro Usuku;Sarah E. Hall;Wataru Matsumoto.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Antigenic oscillations and shifting immunodominance in HIV-1 infections
Martin A. Nowak;Robert M. May;Rodney E. Phillips;Sarah Rowland-Jones.
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
Emmanuel Hanon;Sarah Hall;Sarah Hall;Sarah Hall;Graham P. Taylor;Graham P. Taylor;Graham P. Taylor;Mineki Saito;Mineki Saito;Mineki Saito.
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Jeremy Chataway;Nadine Schuerer;Ali Alsanousi;Dennis Chan.
The Lancet (2014)
The immune control and cell-to-cell spread of human T-lymphotropic virus type 1.
Charles R. M. Bangham.
Journal of General Virology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: